Mary Lynne Hedley Insider Trading $BLUE bluebird bio, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Mary Lynne Hedley.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Mary Lynne Hedley. Mary Lynne Hedley is Exec VP & Chief Scientific Off in MGI PHARMA INC ($MOGN) and Sr. VP & Chief Scientific Off in MGI PHARMA INC ($MOGN) and Director in bluebird bio, Inc. ($BLUE) and Director in VEEVA SYSTEMS INC ($VEEV) and Director in Receptos, Inc. ($RCPT) and PRESIDENT & COO in TESARO, Inc. ($TSRO) and President and COO in TESARO, Inc. ($TSRO) and Director in Millendo Therapeutics, Inc. ($OVAS).

Mary Lynne Hedley in bluebird bio, Inc.

Trading Symbol: BLUE
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Mary Lynne Hedley: Director
Holdings: 3,700 shares
Current Value: $272,690
Latest Transaction: Jun 22 2018
$BLUE Market Capitalization: $2.75B
$BLUE Previous Close: $73.70

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Mary Lynne Hedley in bluebird bio, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, BLUE, MOGN, OVAS, RCPT, TSRO, VEEV

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 22 2018	BLUE	bluebird bio, Inc.	Hedley Mary Lynne	Director	Option Exercise	A	183.10	4,000	732,400	4,000
Jun 22 2018	BLUE	bluebird bio, Inc.	Hedley Mary Lynne	Director	Grant	A	0.00	1,000	0	3,700	2.7 K to 3.7 K (+37.04 %)
Sep 20 2017	BLUE	bluebird bio, Inc.	Hedley Mary Lynne	Director	Option Exercise	A	133.05	10,700	1,423,635	10,700
Sep 20 2017	BLUE	bluebird bio, Inc.	Hedley Mary Lynne	Director	Grant	A	0.00	2,700	0	2,700	0 to 2.7 K

Page: 1